| UniProt ID | WDR20_HUMAN | |
|---|---|---|
| UniProt AC | Q8TBZ3 | |
| Protein Name | WD repeat-containing protein 20 | |
| Gene Name | WDR20 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 569 | |
| Subcellular Localization | ||
| Protein Description | Regulator of deubiquitinating complexes. Activates deubiquitinating activity of complexes containing USP12. [PubMed: 20147737] | |
| Protein Sequence | MATEGGGKEMNEIKTQFTTREGLYKLLPHSEYSRPNRVPFNSQGSNPVRVSFVNLNDQSGNGDRLCFNVGRELYFYIYKGVRKAADLSKPIDKRIYKGTQPTCHDFNHLTATAESVSLLVGFSAGQVQLIDPIKKETSKLFNEERLIDKSRVTCVKWVPGSESLFLVAHSSGNMYLYNVEHTCGTTAPHYQLLKQGESFAVHTCKSKSTRNPLLKWTVGEGALNEFAFSPDGKFLACVSQDGFLRVFNFDSVELHGTMKSYFGGLLCVCWSPDGKYIVTGGEDDLVTVWSFVDCRVIARGHGHKSWVSVVAFDPYTTSVEEGDPMEFSGSDEDFQDLLHFGRDRANSTQSRLSKRNSTDSRPVSVTYRFGSVGQDTQLCLWDLTEDILFPHQPLSRARTHTNVMNATSPPAGSNGNSVTTPGNSVPPPLPRSNSLPHSAVSNAGSKSSVMDGAIASGVSKFATLSLHDRKERHHEKDHKRNHSMGHISSKSSDKLNLVTKTKTDPAKTLGTPLCPRMEDVPLLEPLICKKIAHERLTVLIFLEDCIVTACQEGFICTWGRPGKVVSFNP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MATEGGGKE ------CCCCCCCCH | 17.85 | 22814378 | |
| 8 | Ubiquitination | MATEGGGKEMNEIKT CCCCCCCCHHHHHHC | 58.00 | - | |
| 51 | Phosphorylation | GSNPVRVSFVNLNDQ CCCCEEEEEEECCCC | 16.95 | 27732954 | |
| 59 | Phosphorylation | FVNLNDQSGNGDRLC EEECCCCCCCCCEEE | 36.77 | 27732954 | |
| 76 | Phosphorylation | VGRELYFYIYKGVRK CCCCHHHEHHHCHHH | 6.98 | 18083107 | |
| 139 | Acetylation | PIKKETSKLFNEERL CHHHHHHHHHCHHHH | 65.60 | 25953088 | |
| 150 | Phosphorylation | EERLIDKSRVTCVKW HHHHCCCCCEEEEEE | 28.38 | 21406692 | |
| 153 | Phosphorylation | LIDKSRVTCVKWVPG HCCCCCEEEEEECCC | 15.52 | 21406692 | |
| 161 | Phosphorylation | CVKWVPGSESLFLVA EEEECCCCCEEEEEE | 20.24 | 21406692 | |
| 163 | Phosphorylation | KWVPGSESLFLVAHS EECCCCCEEEEEEEC | 26.56 | 21406692 | |
| 170 | Phosphorylation | SLFLVAHSSGNMYLY EEEEEEECCCCEEEE | 30.15 | 21406692 | |
| 171 | Phosphorylation | LFLVAHSSGNMYLYN EEEEEECCCCEEEEE | 25.07 | 21406692 | |
| 175 | Phosphorylation | AHSSGNMYLYNVEHT EECCCCEEEEEEEEC | 15.27 | 21406692 | |
| 177 | Phosphorylation | SSGNMYLYNVEHTCG CCCCEEEEEEEECCC | 10.32 | 21406692 | |
| 182 | Phosphorylation | YLYNVEHTCGTTAPH EEEEEEECCCCCCCH | 10.10 | 21406692 | |
| 185 | Phosphorylation | NVEHTCGTTAPHYQL EEEECCCCCCCHHHH | 23.18 | 21406692 | |
| 186 | Phosphorylation | VEHTCGTTAPHYQLL EEECCCCCCCHHHHH | 24.39 | 21406692 | |
| 190 | Phosphorylation | CGTTAPHYQLLKQGE CCCCCCHHHHHHCCC | 10.37 | 21406692 | |
| 308 | Phosphorylation | HGHKSWVSVVAFDPY CCCCCEEEEEEECCC | 12.48 | 20068231 | |
| 328 | Phosphorylation | EGDPMEFSGSDEDFQ CCCCCCCCCCCHHHH | 24.87 | 27251275 | |
| 330 | Phosphorylation | DPMEFSGSDEDFQDL CCCCCCCCCHHHHHH | 36.31 | 27251275 | |
| 347 | Phosphorylation | FGRDRANSTQSRLSK HCHHCCHHHHHHHHH | 27.17 | 20363803 | |
| 348 | Phosphorylation | GRDRANSTQSRLSKR CHHCCHHHHHHHHHC | 30.30 | 21406692 | |
| 350 | Phosphorylation | DRANSTQSRLSKRNS HCCHHHHHHHHHCCC | 34.96 | 30576142 | |
| 353 | Phosphorylation | NSTQSRLSKRNSTDS HHHHHHHHHCCCCCC | 28.58 | 20363803 | |
| 357 | Phosphorylation | SRLSKRNSTDSRPVS HHHHHCCCCCCCCEE | 37.31 | 22167270 | |
| 358 | Phosphorylation | RLSKRNSTDSRPVSV HHHHCCCCCCCCEEE | 41.36 | 30266825 | |
| 360 | Phosphorylation | SKRNSTDSRPVSVTY HHCCCCCCCCEEEEE | 38.27 | 30266825 | |
| 364 | Phosphorylation | STDSRPVSVTYRFGS CCCCCCEEEEEECCC | 16.07 | 22167270 | |
| 366 | Phosphorylation | DSRPVSVTYRFGSVG CCCCEEEEEECCCCC | 11.06 | 22167270 | |
| 367 | Phosphorylation | SRPVSVTYRFGSVGQ CCCEEEEEECCCCCC | 11.20 | 23927012 | |
| 371 | Phosphorylation | SVTYRFGSVGQDTQL EEEEECCCCCCCCEE | 21.99 | 20068231 | |
| 407 | Phosphorylation | HTNVMNATSPPAGSN CCCCCCCCCCCCCCC | 36.44 | 24719451 | |
| 408 | Phosphorylation | TNVMNATSPPAGSNG CCCCCCCCCCCCCCC | 26.86 | 21712546 | |
| 420 | Phosphorylation | SNGNSVTTPGNSVPP CCCCCCCCCCCCCCC | 27.35 | 21712546 | |
| 432 | Phosphorylation | VPPPLPRSNSLPHSA CCCCCCCCCCCCCHH | 28.91 | 22167270 | |
| 434 | Phosphorylation | PPLPRSNSLPHSAVS CCCCCCCCCCCHHCC | 44.52 | 22167270 | |
| 438 | Phosphorylation | RSNSLPHSAVSNAGS CCCCCCCHHCCCCCC | 28.55 | 30266825 | |
| 441 | Phosphorylation | SLPHSAVSNAGSKSS CCCCHHCCCCCCCCH | 22.22 | 30266825 | |
| 445 | Phosphorylation | SAVSNAGSKSSVMDG HHCCCCCCCCHHHHH | 27.27 | 30266825 | |
| 447 | Phosphorylation | VSNAGSKSSVMDGAI CCCCCCCCHHHHHHH | 29.84 | 25056879 | |
| 448 | Phosphorylation | SNAGSKSSVMDGAIA CCCCCCCHHHHHHHH | 25.79 | 25056879 | |
| 463 | Phosphorylation | SGVSKFATLSLHDRK CCCCCCCCCCCHHHH | 21.73 | 30266825 | |
| 465 | Phosphorylation | VSKFATLSLHDRKER CCCCCCCCCHHHHHH | 21.21 | 23401153 | |
| 483 | Phosphorylation | KDHKRNHSMGHISSK HHCCCCCCCCCCCCC | 29.97 | 28348404 | |
| 488 | Phosphorylation | NHSMGHISSKSSDKL CCCCCCCCCCCCCCC | 26.49 | 21406692 | |
| 489 | Phosphorylation | HSMGHISSKSSDKLN CCCCCCCCCCCCCCC | 35.63 | 21406692 | |
| 491 | Phosphorylation | MGHISSKSSDKLNLV CCCCCCCCCCCCCEE | 45.80 | 23401153 | |
| 492 | Phosphorylation | GHISSKSSDKLNLVT CCCCCCCCCCCCEEE | 42.36 | 30266825 | |
| 499 | Phosphorylation | SDKLNLVTKTKTDPA CCCCCEEEECCCCHH | 35.84 | 26657352 | |
| 500 | Ubiquitination | DKLNLVTKTKTDPAK CCCCEEEECCCCHHH | 40.31 | - | |
| 505 (in isoform 6) | Phosphorylation | - | 40.67 | 27732954 | |
| 507 (in isoform 6) | Phosphorylation | - | 50.07 | 20068231 | |
| 508 (in isoform 6) | Phosphorylation | - | 32.31 | 20068231 | |
| 510 (in isoform 6) | Phosphorylation | - | 30.44 | 20068231 | |
| 511 | Phosphorylation | DPAKTLGTPLCPRME CHHHCCCCCCCCCHH | 19.05 | 26853621 | |
| 513 (in isoform 6) | Phosphorylation | - | 6.70 | 20068231 | |
| 514 (in isoform 6) | Phosphorylation | - | 1.80 | 20068231 | |
| 518 (in isoform 6) | Phosphorylation | - | 58.07 | 20068231 | |
| 566 (in isoform 2) | Phosphorylation | - | 23.46 | 27732954 | |
| 568 (in isoform 2) | Phosphorylation | - | 33.59 | 20068231 | |
| 569 (in isoform 2) | Phosphorylation | - | 43.51 | 20068231 | |
| 571 (in isoform 2) | Phosphorylation | - | 20068231 | ||
| 574 (in isoform 2) | Phosphorylation | - | 20068231 | ||
| 575 (in isoform 2) | Phosphorylation | - | 20068231 | ||
| 579 (in isoform 2) | Phosphorylation | - | 20068231 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of WDR20_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WDR20_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WDR20_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| COBA2_HUMAN | COL11A2 | physical | 19615732 | |
| ODPA_HUMAN | PDHA1 | physical | 19615732 | |
| PKN2_HUMAN | PKN2 | physical | 19615732 | |
| SURF2_HUMAN | SURF2 | physical | 19615732 | |
| 1433B_HUMAN | YWHAB | physical | 19615732 | |
| 1433F_HUMAN | YWHAH | physical | 19615732 | |
| RPAC1_HUMAN | POLR1C | physical | 19615732 | |
| OPTN_HUMAN | OPTN | physical | 19615732 | |
| UBXN1_HUMAN | UBXN1 | physical | 19615732 | |
| FBXW5_HUMAN | FBXW5 | physical | 19615732 | |
| WDR48_HUMAN | WDR48 | physical | 19615732 | |
| UBP12_HUMAN | USP12 | physical | 19615732 | |
| UBP46_HUMAN | USP46 | physical | 19615732 | |
| WDR48_HUMAN | WDR48 | physical | 20147737 | |
| DAPP1_HUMAN | DAPP1 | physical | 25814554 | |
| UBP12_HUMAN | USP12 | physical | 26462181 | |
| WDR48_HUMAN | WDR48 | physical | 26462181 | |
| ANDR_HUMAN | AR | physical | 26462181 | |
| UBP12_HUMAN | USP12 | physical | 27373336 | |
| FERM2_HUMAN | FERMT2 | physical | 28514442 | |
| FBXW5_HUMAN | FBXW5 | physical | 28514442 | |
| OPTN_HUMAN | OPTN | physical | 28514442 | |
| WDR48_HUMAN | WDR48 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-434, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432 AND SER-434, ANDMASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-357, AND MASSSPECTROMETRY. | |